Blockade of TGF-β is effective in multiple pre-clinical models of experimental pulmonary hypertension (PH), including experimental hypoxia, monocrotaline and exposure to the parasite Schistosoma mansoni3, 6, 7. Here, TGFB1 is linked to pulmonary hypertension.